Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Utter Christine Marie has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Utter Christine Marie is listed as SVP, CHIEF ACCOUNTING OFFICER at PTC THERAPEUTICS, INC. Inside the rolling window, Utter Christine Marie reported no open-market purchases and 5 open-market sales totaling $1.9M in PTCT. The largest disclosed transaction in the window is a sale of 19,686 PTCT shares on Jun 17, 2026, worth $1.5M.
Companies traded
Other insiders at PTCT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Utter Christine Marie made?
Utter Christine Marie has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Utter Christine Marie trade?
Utter Christine Marie has filed SEC Form 4 disclosures for 1 company, including PTCT.
When was Utter Christine Marie's most recent SEC Form 4 filing?
Utter Christine Marie's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Utter Christine Marie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Utter Christine Marie is listed as SVP, CHIEF ACCOUNTING OFFICER.
What is Utter Christine Marie's total buy and sell value in the current window?
Inside the rolling retention window, Utter Christine Marie bought $0 and sold $1.9M based on SEC Form 4 filings.
What was Utter Christine Marie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 19,686 PTCT shares on 2026-06-17, worth $1.5M, per SEC Form 4 filings.